TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors

This study is comparing two chemotherapy regimens — TC (paclitaxel and carboplatin) versus BEP (bleomycin, etoposide, and cisplatin) — in women with rare ovarian tumors called malignant germ cell tumors, to find out which approach is safer and more effective. **You may be eligible if...** - You are a Chinese woman aged 65 or younger - You have been diagnosed with a specific rare type of ovarian germ cell tumor, confirmed by biopsy - Your cancer was newly diagnosed at a moderately advanced to advanced stage - You had your initial surgery within the past 8 weeks - Your blood counts and organ function are within acceptable ranges - Your overall health is reasonably good **You may NOT be eligible if...** - You have severe or uncontrolled medical conditions that prevent surgery or chemotherapy - You have had an organ transplant or have immune system diseases - You have serious mental illness or significant brain dysfunction - You have a history of drug or substance abuse - You have another active cancer - You are currently in another clinical trial Talk to your doctor to see if this trial is right for you.